Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11701
CALL
Pyxis Oncology
PYXS
$238M
| $86.8K | ﹤0.01% |
+75,500
| New | +$266K |
|
11702
PUT
Sensus Healthcare
SRTS
$49.1M
| $86.8K | ﹤0.01% |
+21,800
| New | +$80.8K |
|
|
CCUP
11703
T-REX 2X Long CRCL Daily Target ETF
CCUP
$27.2M
| $86.5K | ﹤0.01% |
19,937
+4,578
| +30% | +$41.8K |
|
11704
Celularity
CELU
$19.8M
| $86.2K | ﹤0.01% |
77,657
+32,901
| +74% | +$59K |
|
|
KIDZ
11705
KIDZ AI Inc Class B
KIDZ
$863K
| $86.1K | ﹤0.01% |
+968
| New | +$275K |
|
|
LOAN
11706
CALL
Manhattan Bridge Capital
LOAN
$47.1M
| $86K | ﹤0.01% |
+18,500
| New | +$91.6K |
|
11707
PUT
Gerdau
GGB
$9.89B
| $85.6K | ﹤0.01% |
23,200
-2,800
| -11% | -$9.79K |
|
11708
Arena Group
AREN
$75.2M
| $85.5K | ﹤0.01% |
21,369
-7,501
| -26% | -$33.6K |
|
11709
PUT
Evolus
EOLS
$488M
| $85.1K | ﹤0.01% |
12,800
-20,300
| -61% | -$138K |
|
|
MMT
11710
Aberdeen Multi-Market Income Fund
MMT
$239M
| $85.1K | ﹤0.01% |
+18,295
| New | +$86.1K |
|
|
MFM
11711
Aberdeen Municipal Income Fund
MFM
$222M
| $84.8K | ﹤0.01% |
+15,626
| New | +$84.2K |
|
|
CRDL
11712
CALL
Cardiol Therapeutics
CRDL
$157M
| $84.7K | ﹤0.01% |
+88,800
| New | +$93K |
|
|
ORBS
11713
Eightco Holdings
ORBS
$259M
| $84.7K | ﹤0.01% |
+48,958
| New | +$230K |
|
|
DGNX
11714
CALL
Diginex Ltd
DGNX
$42.8M
| $84.7K | ﹤0.01% |
+2,538
| New | +$282K |
|
11715
Genelux
GNLX
$121M
| $84.6K | ﹤0.01% |
19,415
-14,828
| -43% | -$80.1K |
|
11716
Research Solutions
RSSS
$72.9M
| $84.6K | ﹤0.01% |
+28,765
| New | +$89.7K |
|
11717
CALL
Titan International
TWI
$465M
| $84.6K | ﹤0.01% |
10,800
-24,900
| -70% | -$195K |
|
11718
PUT
Achieve Life Sciences
ACHV
$672M
| $84.5K | ﹤0.01% |
17,000
-14,100
| -45% | -$61.5K |
|
|
NCTY
11719
The9 Ltd
NCTY
$76.5M
| $84.5K | ﹤0.01% |
13,263
+799
| +6% | +$6.52K |
|
|
FTF
11720
Franklin Limited Duration Income Trust
FTF
$232M
| $84.1K | ﹤0.01% |
+13,673
| New | +$84.2K |
|
11721
PUT
Gain Therapeutics
GANX
$75.9M
| $84K | ﹤0.01% |
+26,100
| New | +$69.7K |
|
11722
Quest Resource Holding
QRHC
$26.8M
| $83.9K | ﹤0.01% |
45,107
-5,519
| -11% | -$9.36K |
|
11723
PUT
Vir Biotechnology
VIR
$1.48B
| $83.8K | ﹤0.01% |
13,900
-2,000
| -13% | -$11.9K |
|
11724
Future FinTech Group
FTFT
$1.57M
| $83.5K | ﹤0.01% |
+6,768
| New | +$163K |
|
11725
PUT
Alector
ALEC
$203M
| $83.5K | ﹤0.01% |
53,500
-10,400
| -16% | -$18.5K |
|
Similar funds
Citadel Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,362 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
- Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
- Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.